Eli Lilly and Company (LLY) Q3 2009 Earnings Results

Eli Lilly Misses on EPS, Stock Down 4.5%

Eli Lilly's earnings report indicates a disappointing quarter with a notable EPS miss, which contributed to a 4.5% decline in stock price. Investors may be concerned about the company's ability to meet expectations moving forward, especially given the lack of guidance. The management's defensive tone suggests they are aware of the challenges ahead and are focusing on long-term strategies.

The print

Key numbers

Actual vs. consensus

Metric	Actual	Expected	Surprise
EPS	$0.86	N/A	-15.52%

Management

Management commentary

Tone: Defensive

Management expressed concerns about the recent performance and highlighted the need for strategic adjustments. They did not provide specific guidance for future quarters.

Management acknowledged the challenges faced during the quarter.

They emphasized a focus on long-term strategies despite the current results.

Eli Lilly Misses on EPS, Stock Down 4.5%

Key numbers

Management commentary

Eli Lilly and Company

More earnings this week

Eli Lilly Misses on EPS, Stock Down 4.5%

Key numbers

Management commentary